why choose us

First received: November 18, 2023

Clinical Trial: The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glioblastoma

Study Type: OBSERVATIONAL


Official Title: The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

Brief Summary: There are no guidelines or prospective studies defining the optimal surgical treatment for gliomas of older patients (?70 years) or those with limited functioning performance at presentation (KPS ?70).Therefore, the decision between resection and biopsy is varied, amongst neurosurgeons internationally and at times even within an instiutition.This study aims to compare the effects of maximal tumor resection versus tissue biopsy on survival, functional, neurological, and quality of life outcomes in these patient…

Read more